Related Experiment Video
Updated: May 20, 2026
08:35
Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Resistant hypertension.
1Department of Family Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA. anthony_viera@med.unc.edu
Journal of the American Board of Family Medicine : JABFM
|July 10, 2012
Summary
Resistant hypertension (RH) management involves assessing medication adherence and ruling out the white-coat effect. Effective treatment includes dietary sodium restriction, adequate diuretic therapy, and considering secondary causes.
Area of Science:
- Cardiology
- Nephrology
- Pharmacology
Background:
- Resistant hypertension (RH) is a significant clinical challenge, defined by uncontrolled blood pressure despite adherence to multiple antihypertensive medications.
- Accurate diagnosis requires ruling out medication non-adherence and the white-coat effect through out-of-office blood pressure monitoring.
- Lifestyle factors like obesity, alcohol intake, and dietary sodium significantly influence RH management.
Purpose of the Study:
- To outline the comprehensive evaluation and management strategies for patients with resistant hypertension.
- To highlight the importance of diuretic therapy and specific drug choices in RH treatment.
- To discuss secondary causes and advanced therapeutic options for refractory cases.
Main Methods:
- Review of current guidelines and evidence-based practices for resistant hypertension.
- Emphasis on diagnostic steps including adherence assessment and out-of-office BP monitoring.
- Discussion of pharmacological interventions, including diuretic selection and add-on therapies.
Main Results:
- Chlorthalidone demonstrates superior blood pressure-lowering effects and potential cardiovascular event reduction compared to hydrochlorothiazide.
- Loop diuretics are indicated for patients with a glomerular filtration rate below 30 mL/min.
- Spironolactone addition is an evidence-based strategy for RH, requiring careful potassium monitoring.
Conclusions:
- Optimal management of RH necessitates a stepwise approach, starting with adherence assessment and lifestyle modifications.
- Appropriate diuretic selection and the addition of mineralocorticoid receptor antagonists like spironolactone are crucial.
- Referral to a hypertension specialist is recommended for complex or refractory cases.
Related Concept Videos
01:28Hypertension I: Introduction
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
01:29Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
01:18Hypertension and Regulation of Blood Pressure
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...